Mode
Text Size
Log in / Sign up

Atrial flutter

Part of Cardiac arrhythmias

Subtypes of Atrial flutter

Typical atrial flutter 1

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for atrial flutter

26 trials tracked for atrial flutter: 9 in phase 3 or 4 and 1 with published results. The most-cited published study has 3 citations.

26Trials tracked
9Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 6 Phase 3 3 Phase 2 3 Other / NA 14
  1. Phase 4 Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion Completed · 3 cited
  2. Phase 4 Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism Completed
  3. Phase 4 Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation Completed
  4. Phase 4 Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8) Completed
  5. Phase 4 Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter Completed
  6. Phase 4 Concentrations of Amiodarone in Fat Tissue During Chronic Treatment Completed
Show 20 more trials
  1. Phase 3 Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery Completed
  2. Phase 3 A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation Completed
  3. Phase 3 Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation Completed
  4. Phase 2 Cardiac Electrophysiological Study Completed
  5. Phase 2 Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm Completed
  6. Phase 2 Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter Completed
  7. N/A Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter Completed
  8. N/A iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology Completed
  9. N/A An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System Completed
  10. N/A FREEZE-AFIB Post-Market Study Completed
  11. N/A Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias Completed
  12. N/A Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias Completed
  13. N/A Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation Completed
  14. N/A Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System for Treatment of Atrial and Ventricular Arrhythmias Completed
  15. N/A Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies Completed
  16. N/A Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus Completed
  17. N/A ArcticLine Feasibility Study Completed
  18. N/A Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial Completed
  19. N/A Wire Instrumentation Using Radiofrequency Energy to Impact Transseptal Efficiency Completed
  20. N/A Comparison of Intracardiac Echocardiography and Transesophageal Echocardiography Completed

Showing the 26 most-cited and recently-updated of 26 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Atrial flutter: what the trials found

Pharmacological management of atrial flutter includes various agents. Dronedarone was associated with a lower rate of first hospitalization for cardiovascular reasons or death from any cause compared to the control group (p<0.0001) 9. While dronedarone showed a significant reduction in hospitalizations, the difference in total deaths from any cause did not reach statistical significance (p=0.18) 9. Warfarin was evaluated for stroke and bleeding; it demonstrated significantly lower rates of adjudicated stroke or systemic embolism (p=0.0114) and significantly lower rates of major bleed events (p<0.0001) compared to the comparison group, while all-cause death rates were also significantly lower (p=0.0465) 8.

Interventional procedures for atrial flutter show high efficacy in achieving conduction block and success rates. RF energy delivery for typical atrial flutter resulted in a 93.3% rate of complete bidirectional conduction block (p=0.05) with a low incidence of cardiovascular-specific adverse events within seven days (1.5%, p=0.05) 4. The use of a gold tip catheter showed significant success with the first catheter (p=0.042), though duration of energy application did not differ significantly between groups (p=0.25) 5. Long-term treatment success was observed in patients treated with gold tip catheters, showing no statistically significant difference between groups (p=0.53) 5.

Other established interventions and technologies include the use of propofol 1, beta blockers 7, dabigatran etexilate mesylate 3, fat tissue needle aspiration 6, and specialized mapping systems such as the Sphere-9 Catheter and Affera Mapping and Ablation System, which reported a 19% rate of subjects free from documented recurrence 14.

Recent results — preliminary, needs further review

  • Amiodarone weight-based dosing showed specific steady-state concentrations (p-values not provided) 10.
  • AliveCor technology was associated with lower rates of atrial arrhythmia recurrence and shorter time to treatment for recurrence compared to the control group (p=0.05) 16.
  • ArcticLine Cardiac Cryoablation Catheter showed zero primary safety events within 7 days post-procedure 20.

For the clinician treating this condition

  • Dronedarone significantly reduces the risk of hospitalization for cardiovascular reasons or death compared to standard care 9.
  • Warfarin is associated with lower rates of stroke, systemic embolism, and major bleeding in patients undergoing treatment 8.
  • RF energy delivery for typical atrial flutter achieves a high rate of complete bidirectional conduction block (93.3%) with low early adverse events 4.

AI synthesis of 12 cited trials, updated Jun 26, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Cardiac arrhythmias

Related studies from across the Cardiac arrhythmias family.

Animal models of pulmonary hypertension and hypoxia provide evidence of right atrial remodeling in atrial fibrillation
Cardiology Sys. Review
Animal models of pulmonary hypertension and hypoxia provide evidence of right atrial remodeling in atrial fibrillation New Research Methods Help Identify Heart Issues Linked to Lung Pressure
This narrative review synthesizes evidence from various animal models, including MCT, SuHx, CIH, and PAB, regarding right atrial involvement…
Researchers are finding better ways to study how high blood pressure in the lungs leads to irregular heartbeats.
Higher HbA1c levels associated with increased atrial fibrillation burden in non-diabetic patients
Cardiology RCT
Higher HbA1c levels associated with increased atrial fibrillation burden in non-diabetic patients Higher Blood Sugar Levels Linked to Increased Atrial Fibrillation Burden
This post-hoc analysis of 884 individuals undergoing implantable loop recorder screening found that higher HbA1c levels were associated with…
Higher blood sugar levels are linked to a greater burden of atrial fibrillation, potentially impacting how the heart rhythm progresses over …
Metabolic syndrome increases risk of incident atrial fibrillation by 1.4- to 1.9-fold
Cardiology Sys. Review
Metabolic syndrome increases risk of incident atrial fibrillation by 1.4- to 1.9-fold Metabolic Syndrome Increases Risk of Atrial Fibrillation in Patients
This narrative review examines the association between metabolic syndrome and atrial fibrillation incidence. The authors synthesize evidence…
Metabolic syndrome is linked to a higher risk of atrial fibrillation, with high blood pressure and abdominal obesity showing the strongest c…
Conscious or deep sedation reduces procedural time in pulsed field ablation for atrial fibrillation
Cardiology Meta-analysis
Conscious or deep sedation reduces procedural time in pulsed field ablation for atrial fibrillation Comparing Sedation and General Anesthesia for Pulsed Field Ablation of Atrial Fibrillation
This meta-analysis of 10 studies involving 3,692 patients found that conscious or deep sedation (CS/DS) significantly shortened overall proc…
Doctors are finding that using light sedation instead of full general anesthesia can speed up heart procedures without hurting safety.
Yangxin Dingji plus conventional therapy reduces 6-month atrial fibrillation recurrence and improves LVEF
Drug Pipeline Meta-analysis
Yangxin Dingji plus conventional therapy reduces 6-month atrial fibrillation recurrence and improves LVEF Yangxin Dingji Combined With Standard Care Shows Promise for Atrial Fibrillation
This meta-analysis of 872 patients evaluated Yangxin Dingji (YXDJ) as an adjunct to conventional therapy for atrial fibrillation. The study …
Adding Yangxin Dingji to standard treatment may improve symptoms and reduce the risk of heart rhythm recurrence in patients with atrial fibr…
Left atrial appendage occlusion reduces non-procedure-related bleeding but may increase ischemic stroke risk
Cardiology Meta-analysis
Left atrial appendage occlusion reduces non-procedure-related bleeding but may increase ischemic stroke risk LAAO Procedure Shows Mixed Results Compared to Oral Anticoagulants
This meta-analysis of 5,890 randomized patients evaluated left atrial appendage occlusion (LAAO) compared to oral anticoagulation for atrial…
A procedure called LAAO can reduce certain types of bleeding but may increase stroke risk compared to standard oral medications for heart pa…
Mortality Risk Factors in Atrial Fibrillation: Umbrella Review Findings
Cardiology Sys. Review
Mortality Risk Factors in Atrial Fibrillation: Umbrella Review Findings Specific risk factors linked to higher death rates in atrial fibrillation
An umbrella review found 86 of 216 risk factors significantly linked to mortality in atrial fibrillation, including several medications and …
New data identifies specific medications and health conditions that may increase the risk of death for people living with atrial fibrillatio…
Vascular closure devices reduce time to hemostasis by 5.63 minutes in atrial fibrillation ablation
Cardiology Meta-analysis
Vascular closure devices reduce time to hemostasis by 5.63 minutes in atrial fibrillation ablation Vascular closure devices speed up bleeding control in heart procedures
This meta-analysis of 30,560 patients undergoing atrial fibrillation ablation found that vascular closure devices (VCDs) significantly reduc…
New data shows that vascular closure devices help stop bleeding faster during atrial fibrillation procedures, though they do not change disc…
Empiric superior vena cava isolation reduces atrial tachyarrhythmia recurrence compared to pulmonary vein isolation alone
Cardiology Meta-analysis
Empiric superior vena cava isolation reduces atrial tachyarrhythmia recurrence compared to pulmonary vein isolation alone Adding a specific step can reduce heart rhythm issues
This meta-analysis of randomized controlled trials evaluated superior vena cava isolation (SVCI) as an adjunct to pulmonary vein isolation (…
Adding a technique called superior vena cava isolation can significantly lower the chances of heart rhythm issues returning after surgery.
Single transseptal puncture is a safe alternative to double puncture for atrial fibrillation ablation
Cardiology Meta-analysis
Single transseptal puncture is a safe alternative to double puncture for atrial fibrillation ablation Single Transseptal Puncture Is Safe for Atrial Fibrillation Ablation
This meta-analysis of 1811 patients evaluated single versus double transseptal puncture during atrial fibrillation ablation. The analysis fo…
A single transseptal puncture is a safe alternative to double puncture during atrial fibrillation procedures, despite taking more time to co…
Extended rhythm monitoring identifies 64% of asymptomatic atrial fibrillation in patients on BTKi therapy
Cardiology Meta-analysis
Extended rhythm monitoring identifies 64% of asymptomatic atrial fibrillation in patients on BTKi therapy BTK Inhibitors Linked to Hidden Heart Rhythm Problem in Cancer Patients
This meta-analysis of 2839 patients with hematologic malignancies treated with Bruton's tyrosine kinase inhibitors (BTKi) found an overall a…
A meta-analysis of 2,839 patients found that 14% of atrial fibrillation cases during BTK inhibitor therapy had no symptoms.
Remote ischemic preconditioning reduces postoperative atrial fibrillation in patients with specific genetic risk factors
Cardiology RCT
Remote ischemic preconditioning reduces postoperative atrial fibrillation in patients with specific genetic risk factors Trial Shows Remote Ischemic Preconditioning Reduces Heart Rhythm Issues
Researchers investigated the impact of remote ischemic preconditioning on patients with a specific genetic profile undergoing coronary arter…
A new trial shows that a specific preconditioning technique may reduce the risk of heart rhythm problems after heart bypass surgery.